Want to join the conversation?
$ISRG expects full year 2015 procedure growth of between 13-14%. 4Q15 pro forma gross profit margin is expected to be between a range of 67.5-68.5% of revenue. This range is a bit lower than 3Q15 gross margin, as the quarter benefited from favorable product mix and other factors, which $ISRG expects to return to more typical patterns in 4Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?